IGF1R and cancer: Briefly, CD146- fibroblasts were able to activate IGF1R tyrosine kinase signalling in the cancer cells that drove their oestrogen-independent growth, and was, therefore, hypothesised to be the cause of the irresponsiveness of cancer cells to the treatment [95].